It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Complaints of sleep disturbance are prevalent among breast cancer (BC) patients and are predictors of quality of life. Still, electrophysiological measures of sleep are missing in patients, which prevents from understanding the pathophysiological consequences of cancer and its past treatments. Using polysomnography, sleep can be investigated in terms of macro- (e.g. awakenings, sleep stages) and micro- (i.e. cortical activity) structure. We aimed to characterize sleep complaints, and macro- and microstructure in 33 BC survivors untreated by chemotherapy and that had finished radiotherapy since at least 6 months (i.e. out of the acute effects of radiotherapy) compared to 21 healthy controls (HC). Compared to HC, BC patients had a larger number of awakenings (p = 0.008); and lower Delta power (p < 0.001), related to sleep deepening and homeostasis; greater both Alpha (p = 0.002) and Beta power (p < 0.001), related to arousal during deep sleep; and lower Theta power (p = 0.004), related to emotion regulation during dream sleep. Here we show that patients have increased cortical activity related to arousal and lower activity related to sleep homeostasis compared to controls. These results give additional insights in sleep pathophysiology of BC survivors and suggest sleep homeostasis disruption in non-advanced stages of BC.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Normandie Univ, UNICAEN, PSL Université, EPHE, INSERM, U1077, CHU de Caen, GIP Cyceron, Neuropsychologie Et Imagerie de La Mémoire Humaine, Caen, France (GRID:grid.411149.8) (ISNI:0000 0004 0472 0160)
2 Departments of Clinical Research Unit and Medical Oncology, Caen, France (GRID:grid.411149.8); Centre François Baclesse, Institut Normand du Sein, Caen, France (GRID:grid.418189.d) (ISNI:0000 0001 2175 1768)
3 Departments of Clinical Research Unit and Medical Oncology, Caen, France (GRID:grid.418189.d); Centre François Baclesse, Institut Normand du Sein, Caen, France (GRID:grid.418189.d) (ISNI:0000 0001 2175 1768)
4 Departments of Clinical Research Unit and Medical Oncology, Caen, France (GRID:grid.411149.8); Centre François Baclesse, Institut Normand du Sein, Caen, France (GRID:grid.418189.d) (ISNI:0000 0001 2175 1768); CHU Côte de Nacre, Caen, France (GRID:grid.411149.8) (ISNI:0000 0004 0472 0160); INSERM, Normandie Univ, UNICAEN, U1086 ANTICIPE, Caen, France (GRID:grid.412043.0) (ISNI:0000 0001 2186 4076); Ligue Nationale Contre Le Cancer, Cancer and Cognition Platform, Caen, France (GRID:grid.452770.3) (ISNI:0000 0001 2226 6748)
5 Normandie Univ, UNICAEN, PSL Université, EPHE, INSERM, U1077, CHU de Caen, GIP Cyceron, Neuropsychologie Et Imagerie de La Mémoire Humaine, Caen, France (GRID:grid.411149.8) (ISNI:0000 0004 0472 0160); Ligue Nationale Contre Le Cancer, Cancer and Cognition Platform, Caen, France (GRID:grid.452770.3) (ISNI:0000 0001 2226 6748)